Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study PA Gurbel, KP Bliden, K Guyer, PW Cho, KA Zaman, RP Kreutz, AK Bassi, ... Journal of the American College of Cardiology 46 (10), 1820-1826, 2005 | 860 | 2005 |
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ... JACC: Cardiovascular Interventions 11 (2), 181-191, 2018 | 271 | 2018 |
Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019 TK Maatman, F Jalali, C Feizpour, II Anthony Douglas, SP McGuire, ... Critical care medicine 48 (9), e783-e790, 2020 | 194 | 2020 |
Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study RP Kreutz, EJ Stanek, R Aubert, J Yao, JA Breall, Z Desta, TC Skaar, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 30 (8 …, 2010 | 180 | 2010 |
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype‐Guided Antiplatelet Therapy PE Empey, JM Stevenson, S Tuteja, KW Weitzel, DJ Angiolillo, ... Clinical Pharmacology & Therapeutics 104 (4), 664-674, 2018 | 117 | 2018 |
Pharmacogenomics of novel direct oral anticoagulants: newly identified genes and genetic variants SH Kanuri, RP Kreutz Journal of personalized medicine 9 (1), 7, 2019 | 114 | 2019 |
Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study US Tantry, KP Bliden, TA Suarez, RP Kreutz, J Dichiara, PA Gurbel Platelets 21 (5), 360-367, 2010 | 98 | 2010 |
Quantification of intact quadriceps tendon, quadriceps tendon insertion, and suprapatellar fat pad: MR arthrography, anatomy, and cryosections in the sagittal plane RW Staeubli H U , Bollmann C , Kreutz R , Becker W Am J Roentgenol 173 (3), 691-8, 1999 | 94* | 1999 |
A comprehensive review and meta-analysis of risk factors for statin-induced myopathy KA Nguyen, L Li, D Lu, A Yazdanparast, L Wang, RP Kreutz, EC Whipple, ... European journal of clinical pharmacology 74, 1099-1109, 2018 | 84 | 2018 |
Platelet function measured by VerifyNow™ identifies generalized high platelet reactivity in aspirin treated patients J Dichiara, KP Bliden, US Tantry, SK Chaganti, RP Kreutz, TB Gesheff, ... Platelets 18 (6), 414-423, 2007 | 77 | 2007 |
A national study of the effect of individual proton pump inhibitors on cardiovascular outcomes in patients treated with clopidogrel following coronary stenting: the Clopidogrel … EJ Stanek, RE Aubert, DA Flockhart, RP Kreutz, J Yao, JA Breall, Z Desta, ... Paper presented al SCAI 32nd Annual Scientific Sessions. Las Vegas NV, 2009 | 68 | 2009 |
The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stenting PA Gurbel, KP Bliden, RP Kreutz, J Dichiara, MJ Antonino, US Tantry Platelets 20 (2), 97-104, 2009 | 68 | 2009 |
Implementation of a pharmacogenomics consult service to support the INGENIOUS trial MT Eadon, Z Desta, KD Levy, BS Decker, RC Pierson, VM Pratt, ... Clinical Pharmacology & Therapeutics 100 (1), 63-66, 2016 | 66 | 2016 |
Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity RP Kreutz, M Alloosh, K Mansour, Z Neeb, Y Kreutz, DA Flockhart, ... Diabetes, metabolic syndrome and obesity: targets and therapy, 99-105, 2011 | 59 | 2011 |
Personalizing antithrombotic therapy in COVID-19: role of thromboelastography and thromboelastometry R Chaudhary, RP Kreutz, KP Bliden, US Tantry, PA Gurbel Thrombosis and haemostasis 120 (11), 1594-1596, 2020 | 55 | 2020 |
Race and sex differences in thrombogenicity: risk of ischemic events following coronary stenting PA Gurbel, KP Bliden, E Cohen, IA Navickas, A Singla, MJ Antonino, ... Blood coagulation & fibrinolysis 19 (4), 268-275, 2008 | 55 | 2008 |
Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: a … PA Gurbel, RP Kreutz, KP Bliden, J DiChiara, US Tantry American heart journal 155 (1), 56-61, 2008 | 49 | 2008 |
Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin RP Kreutz, P Nystrom, Y Kreutz, J Miao, R Kovacs, Z Desta, DA Flockhart, ... Platelets 24 (2), 145-150, 2013 | 48 | 2013 |
Viral respiratory tract infections increase platelet reactivity and activation: an explanation for the higher rates of myocardial infarction and stroke during viral illness RP Kreutz, KP Bliden, US Tantry, PA Gurbel Journal of Thrombosis and Haemostasis 3 (9), 2108-2109, 2005 | 44 | 2005 |
CYP2C19 Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings AL Beitelshees, CD Thomas, PE Empey, GA Stouffer, DJ Angiolillo, ... Journal of the American Heart Association 11 (4), e024159, 2022 | 41 | 2022 |